We manufacture and sell immune cells for cancer treatment, and our aim is to provide more effective regenerative cell therapies for patients from the research and development stages. Our core business is the production and sale of immune cells to provide people with health, and our goal is to become a major global player in cellular medicine, opening the door to tomorrow’s cancer treatments. Unlike the three conventional standard cancer therapies (surgery, radiation, and anticancer drugs), immunotherapy is a treatment that allows patients’ own immune systems to eliminate cancer cells. One of our strengths is our technologies that draw from a decade of accumulated treatment experience, which enables us to provide individualized treatments. This allows us to provide the best treatments without any bias toward specific treatments.